M K Proteins DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024


0.72×	0.73×	0.73×	0.72×
0.82×	0.85×	0.95×	0.96×
2.1%	2.9%	4.5%	6.6%
2.93×	2.93×	2.36×	2.55×
1.72×	1.72×	1.88×	1.58×
6.2%	9.0%	13.9%	18.3%
9.4%	9.4%	12.9%	18.4%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

MKPL₹3.65

M K Proteins Limited

· FMCG & Retail

₹ CrorePeersROML HALDER NKIND GOKUL KRITINUT SUNDROPMcap ₹137 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.72	0.73	0.73	0.72
Interest Burden (Pretax/EBIT) ×	0.96	0.95	0.85	0.82
EBIT Margin %	6.55	4.51	2.87	2.07
Asset Turnover ×	2.55	2.36	2.93	2.93
Financial Leverage (Assets/Equity) ×	1.58	1.88	1.72	1.72
ROE (5-step product, year-end total equity) %	18.35	13.91	8.99	6.18
ROE (owners' profit / average owners' equity) %	18.36	12.87	9.37	9.37

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.